Cited by 12Optimal Experimental Design MethodsStatistical Methods in Clinical TrialsComputational Drug Discovery Methods

A Two-Stage Response Surface Approach to Modeling Drug Interaction

Zhao, Wei, Zhang, Lanju, Zeng, Lingmin, Yang, Harry·2012·Statistics in Biopharmaceutical Research

Abstract

Studies of drug combinations have become increasingly important, especially in treating malignant cancers. Researchers are interested in identifying compounds that act synergistically when combined. Such synergy is usually measured through an interaction index. The existing statistical methods, in general, estimate the interaction index using pooled data from compounds administered individually and in combination. In this article, we propose a two-stage response surface approach. Parameters of monotherapy dose–response curves are estimated and then incorporated in estimating the interaction index through a quadratic response surface model. Using multiple simulation studies, we demonstrate that the new method gives less biased estimates for both monotherapy dose–response curves and interaction index. Also developed is a bootstrapping method that allows constructing a confidence interval for interaction index at any combination dose levels. An example is provided to illustrate the method.

Integrity signals

Registry

Crossref · 10.1080/19466315.2012.707087

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Zhao et al.'s simulations indicated that two-stage models gave results almost identical to the true values of the interaction index, whereas the one-stage model gave interaction indexes that deviated from true values.

    “Their simulations indicated that two-stage models gave results almost identical to the true values of the interaction index. The one-stage model, in contrast, gave interaction indexes that deviated from true values.”
  • Zhao et al. (2012) found that one-stage modeling sometimes could not converge to proper values or had error messages in parameter estimation, but two-stage modeling could overcome these problems.

    “They also found that the one-stage modeling sometimes could not converge to proper values or had error messages in the estimating of parameters, but two-stage modeling could overcome these problems.”
  • From Zhao et al.'s simulation data, even though the one-stage method gives less accurate results than the two-stage method, the differences are not large enough to make different conclusions based on the estimated interaction indexes.

    “From their simulation data, it is worth noting that even though the one-stage method gives less accurate results than the two-stage method, the differences are not large enough to make different conclusions based on the estimated interaction indexes.”
  • Zhao et al. (2012) pointed out that one-stage models may deviate significantly from their true values, and thus potentially lead to wrong conclusions.

    “Zhao et al (2012) has pointed out that one-stage models may deviate significantly from their true values, and thus potentially lead to wrong conclusions.”
  • By incorporating the variance from the first stage into the second stage, the two-stage modeling provides more reliable inference.

    “And by incorporating the variance from the first stage into the second stage, the two-stage modeling provides more reliable inference (Zhao et al. 2012).”

Cited by

Sorted by citations

Authors
Zhao, W., Zhang, L., Zeng, L., & Yang, H.
Venue
Statistics in Biopharmaceutical Research
Published
2012-10
Volume
4
Issue
4
Pages
375-383
ISSN
1946-6315 (ISSN-L)
OpenAlex
W2035267407
Cited by
12
References
0
Citations by year
2023: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 1
FWCI
1.27
Type
journal article
Language
en
Open access
closed
Locations
Statistics in Biopharmaceutical Research (publishedVersion)
Topics
  • Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
drug interactions, combination therapy, synergistic effect, interaction index, quadratic response surface, bootstrapping, confidence intervals, cancer chemotherapy, dose-response modeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review